Combination chemotherapy of abraxane and carboplatin in elderly patients with advanced squamous cell lung cancer, phase 1/2 study (TORG1322)

Trial Profile

Combination chemotherapy of abraxane and carboplatin in elderly patients with advanced squamous cell lung cancer, phase 1/2 study (TORG1322)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 31 May 2016

At a glance

  • Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
  • Indications Lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top